Inventiva S.A. American Depository Shares (IVA)
Stock · NASDAQ · Health Care
$4.71as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$5.19
Industry
Biotechnology: Pharmaceutical Preparations
About IVA
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odip…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 69
- Website
- inventivapharma.com/
Fundamentals
- 1-day range
- $4.62$4.83
- Market cap
- $1.10B
- P/E (trailing)
- —
- P/E (forward)
- -5.65
- EPS (trailing)
- $-2.29
- Dividend yield
- —
- Beta
- -0.50
- Avg. volume
- 1.08M
52-week range
$2.88$6.2
Next earnings: September 25, 2026confirmed
Forecasts
13 analyst ratings
Buy 94%
Hold 6%
Sell 0%
1-year price forecast
High
$26
+452.6%
Median
$13
+176.3%
Low
$8.8
+87.0%
Inventiva S.A. American Depository Shares Competitors
Chosen by industry and closest market cap.
- IVAInventiva S.A. American Depository Shares$4.71▼ 3.98%Market cap $1.10BP/E —$2.88$6.2
- LXRXLexicon Pharmaceuticals Inc. Common Stock$2.29▼ 1.29%Market cap $1.05BP/E —$1.03$2.68
- CRVSCorvus Pharmaceuticals Inc. Common Stock$14.15▼ 3.87%Market cap $1.17BP/E —$5.28$26.95
- OLMAOlema Pharmaceuticals Inc. Common Stock$10.28▼ 4.77%Market cap $1.03BP/E —$5.36$36.26
- SVRASavara Inc. Common Stock$5.27▼ 4.10%Market cap $1.19BP/E —$3.19$7.01
- GERNGeron Corporation Common Stock$1.51▼ 1.63%Market cap $1.01BP/E —$1.04$2.01
- ARDXArdelyx Inc. Common Stock$3.81▼ 0.26%Market cap $1.20BP/E —$3.73$8.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IVA Inventiva S.A. American Depository Shares | $1.10B | — | $4.71 | ▼ 3.98% | $2.88$6.2 |
| LXRX Lexicon Pharmaceuticals Inc. Common Stock | $1.05B | — | $2.29 | ▼ 1.29% | $1.03$2.68 |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | $1.17B | — | $14.15 | ▼ 3.87% | $5.28$26.95 |
| OLMA Olema Pharmaceuticals Inc. Common Stock | $1.03B | — | $10.28 | ▼ 4.77% | $5.36$36.26 |
| SVRA Savara Inc. Common Stock | $1.19B | — | $5.27 | ▼ 4.10% | $3.19$7.01 |
| GERN Geron Corporation Common Stock | $1.01B | — | $1.51 | ▼ 1.63% | $1.04$2.01 |
| ARDX Ardelyx Inc. Common Stock | $1.20B | — | $3.81 | ▼ 0.26% | $3.73$8.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 52.32M
- Total value held
- $289.87M
- Institutional holders
- 65
Top holders this quarter
- Unknown5.19M
- Unknown4.97M
- Unknown4.00M
- Unknown2.99M
- Unknown2.66M
- Unknown2.46M
- Unknown2.35M
- Unknown2.32M
- Unknown2.17M
- Unknown2.13M
See the full, filterable feed with live charts on the MarketWall dashboard.